Search research articles
Contact Us
Filters
Showing results (91-100 of 200) with videos related to
Page
of 20
Sort By:
The American Journal of Pathology
|
May 21, 2021
Proprotein Convertase Subtilisin/Kexin Type 9: A View beyond the Canonical Cholesterol-Lowering Impact
Chiara Macchi, Nicola Ferri, Cesare R Sirtori, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
February 17, 2007
Simvastatin reduces MMP1 expression in human smooth muscle cells cultured on polymerized collagen by inhibiting Rac1 activation
Nicola Ferri, Giulia Colombo, Corrado Ferrandi, et al.
Atherosclerosis Plus
|
October 22, 2024
Lipoprotein(a) and the atherosclerotic burden - Should we wait for clinical trial evidence before taking action?
Isabella Fichtner, Chiara Macchi, Alessandra Stefania Rizzuto, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology
|
June 13, 2024
Lipid-lowering approaches to manage statin-intolerant patients
Massimiliano Ruscica, Alessandra Bertoletti, Cecilia Gobbi, et al.
Pharmacological Reviews
|
June 5, 2026
Are we underestimating the benefits of lipid-lowering therapies?
Angela Pirillo, Manuela Casula, Elena Olmastroni, et al.
Atherosclerosis
|
October 23, 2018
Cholesteryl ester transfer protein: An enigmatic pharmacology - Antagonists and agonists
Shizuya Yamashita, Massimiliano Ruscica, Chiara Macchi, et al.
Biochemical and Biophysical Research Communications
|
October 18, 2012
Upregulation of lectin-like oxidized low density lipoprotein receptor 1 (LOX-1) expression in human endothelial cells by modified high density lipoproteins
Angela Pirillo, Patrizia Uboldi, Nicola Ferri, et al.
Pharmacology & Therapeutics
|
August 11, 2023
Beyond statins: New pharmacological targets to decrease LDL-cholesterol and cardiovascular events
Emanuel Raschi, Manuela Casula, Arrigo F G Cicero, et al.
Pharmacological Research
|
September 13, 2022
Pharmacological rationale for the very early treatment of acute coronary syndrome with monoclonal antibodies anti-PCSK9
Nicola Ferri, Massimiliano Ruscica, Maria Giovanna Lupo, et al.
Pharmacological Research
|
July 25, 2018
Pharmacokinetic drug interactions of the non-vitamin K antagonist oral anticoagulants (NOACs)
Paolo Gelosa, Laura Castiglioni, Marco Tenconi, et al.
Page
of 20
Search research articles
Search
Showing results (91-100 of 200) with videos related to
Sort By:
Page
of 20
The American Journal of Pathology
|
May 21, 2021
Proprotein Convertase Subtilisin/Kexin Type 9: A View beyond the Canonical Cholesterol-Lowering Impact
Chiara Macchi, Nicola Ferri, Cesare R Sirtori, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
February 17, 2007
Simvastatin reduces MMP1 expression in human smooth muscle cells cultured on polymerized collagen by inhibiting Rac1 activation
Nicola Ferri, Giulia Colombo, Corrado Ferrandi, et al.
Atherosclerosis Plus
|
October 22, 2024
Lipoprotein(a) and the atherosclerotic burden - Should we wait for clinical trial evidence before taking action?
Isabella Fichtner, Chiara Macchi, Alessandra Stefania Rizzuto, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology
|
June 13, 2024
Lipid-lowering approaches to manage statin-intolerant patients
Massimiliano Ruscica, Alessandra Bertoletti, Cecilia Gobbi, et al.
Pharmacological Reviews
|
June 5, 2026
Are we underestimating the benefits of lipid-lowering therapies?
Angela Pirillo, Manuela Casula, Elena Olmastroni, et al.
Atherosclerosis
|
October 23, 2018
Cholesteryl ester transfer protein: An enigmatic pharmacology - Antagonists and agonists
Shizuya Yamashita, Massimiliano Ruscica, Chiara Macchi, et al.
Biochemical and Biophysical Research Communications
|
October 18, 2012
Upregulation of lectin-like oxidized low density lipoprotein receptor 1 (LOX-1) expression in human endothelial cells by modified high density lipoproteins
Angela Pirillo, Patrizia Uboldi, Nicola Ferri, et al.
Pharmacology & Therapeutics
|
August 11, 2023
Beyond statins: New pharmacological targets to decrease LDL-cholesterol and cardiovascular events
Emanuel Raschi, Manuela Casula, Arrigo F G Cicero, et al.
Pharmacological Research
|
September 13, 2022
Pharmacological rationale for the very early treatment of acute coronary syndrome with monoclonal antibodies anti-PCSK9
Nicola Ferri, Massimiliano Ruscica, Maria Giovanna Lupo, et al.
Pharmacological Research
|
July 25, 2018
Pharmacokinetic drug interactions of the non-vitamin K antagonist oral anticoagulants (NOACs)
Paolo Gelosa, Laura Castiglioni, Marco Tenconi, et al.
Page
of 20